|
|
|
|
Treatment of small, asymptomatic, unruptured cerebral aneurysms in patients without a history of SAH worsens clinical outcomes, and thus is neither effective nor cost-effective. For aneurysms that are >/= 10 mm or symptomatic, or in patien ts with a history of SAH, treatment appears to be cost-effective. |
|